Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (3)

2025

  1. Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study

    HemaSphere, Vol. 9, Núm. 4

2024

  1. Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study

    Cytometry Part B - Clinical Cytometry, Vol. 106, Núm. 4, pp. 252-263

2022

  1. ALL-268 Genetic Classification of B-Cell Precursor Adult Acute Lymphoblastic Leukemia Patients Enrolled in LAL19 Trial from the Pethema Group: Response to Treatment and Survival

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S199